Anticoagulation therapy: Reducing factor XI with antisense oligonucleotides superior to endoxaparin for postoperative venous thromboembolism
- PMID: 25533800
- DOI: 10.1038/nrcardio.2014.214
Anticoagulation therapy: Reducing factor XI with antisense oligonucleotides superior to endoxaparin for postoperative venous thromboembolism
Comment on
-
Making (anti)sense of factor XI in thrombosis.N Engl J Med. 2015 Jan 15;372(3):277-8. doi: 10.1056/NEJMe1413874. Epub 2014 Dec 7. N Engl J Med. 2015. PMID: 25482334 No abstract available.
-
Factor XI antisense oligonucleotide for prevention of venous thrombosis.N Engl J Med. 2015 Jan 15;372(3):232-40. doi: 10.1056/NEJMoa1405760. Epub 2014 Dec 7. N Engl J Med. 2015. PMID: 25482425 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical